Private company
Darwin Global Management, Ltd.
Last updated Oct 21, 2026.
Overview
- HeadquartersY91
Corporate structure
Darwin Global Management, Ltd. is part of a group headed by Dgm Holdings. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of Darwin Global Management, Ltd.
- Abhishek Nmn Trehan Owns 75% or more of Dgm Holdings, since 11/2020 (Form ADV)
- Charl Michael Grobler Owns control (general partner, trustee or manager) of Dgm Holdings, since 11/2024 (Form ADV)
- Dgm Holdings
- Darwin Global Management, Ltd. Y9
- Ambrx Biopharma Cayman, Inc. Stake · La Jolla, California
- BELITE BIO, INC Stake · Grand Cayman, Cayman Islands
- GENMAB A/S Stake
- INSMED Inc Stake · Bridgewater, New Jersey, United States
- TG Therapeutics Stake · New York, New York, United States
- Darwin Global Management, Ltd. Y9
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (5 companies); owners and owned firms from Form ADV, the registration investment advisers file with the SEC. Each entity in the chart links to its source.
Investment adviser
Darwin Global Management, Ltd. is registered with the SEC as an investment adviser. This is what it reports on Form ADV, the registration every adviser files and keeps current.
- RegistrationSEC 802-120364, CRD 312512 IAPD record
Who owns it
Owners of 5% or more as the firm lists them (Schedule A), and the owners of those owners up the chain (Schedule B).
- DGM HOLDINGSowns 75% or more, since 11/2020
- Charl Michael Groblerowns general partner, trustee or manager of DGM HOLDINGS, since 11/2024
- Abhishek Nmn Trehanowns 75% or more of DGM HOLDINGS, since 11/2020
Filings
23 filings to the SEC since October 2021: 23 other. The latest 20:
- Aug 31, 2026N-PX EDGAR
- Aug 14, 202613F-HR EDGAR
- May 15, 202613F-HR EDGAR
- Feb 17, 202613F-HR EDGAR
- Nov 14, 202513F-HR EDGAR
- Sep 2, 2025N-PX EDGAR
- Aug 14, 202513F-HR EDGAR
- May 15, 202513F-HR EDGAR
- Feb 14, 202513F-HR EDGAR
- Nov 14, 202413F-HR EDGAR
- Aug 14, 202413F-HR EDGAR
- Jul 30, 2024N-PX EDGAR
- May 15, 202413F-HR EDGAR
- Feb 14, 202413F-HR EDGAR
- Nov 14, 202313F-HR EDGAR
- Aug 14, 202313F-HR EDGAR
- May 15, 202313F-HR EDGAR
- Feb 14, 202313F-HR EDGAR
- Nov 14, 202213F-HR EDGAR
- Aug 15, 202213F-HR EDGAR
The 23 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Darwin Global Management, Ltd. has told the SEC it owns more than 5% of 5 companies, latest first (Schedules 13D and 13G).
- GENMAB A/SSCHEDULE 13G Oct 5, 20263
- INSMED IncSCHEDULE 13G/A Sep 3, 2024 to Aug 14, 20264
- BELITE BIO, INCSCHEDULE 13G/A Dec 10, 2025 to Feb 17, 20265
- TG TherapeuticsSC 13G/A Apr 3, 2023 to Nov 14, 20246
- Ambrx Biopharma Cayman, Inc.SC 13D/A Dec 19, 2022 to Jun 28, 20237
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7